Wiley Bros. Aintree Capital, LLC Dexcom Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 21,750 shares of DXCM stock, worth $1.27 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,750
Previous 22,920
5.1%
Holding current value
$1.27 Million
Previous $1.57 Million
21.28%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,106Shares Held
366MCall Options Held
5.36MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$2.81 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.01 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$981 Million0.06% of portfolio
-
Baillie Gifford & CO15.9MShares$925 Million0.84% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$627 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...